APEH and prostate cancer: To investigate for the first time the immunosuppressive activity of gp41 on the T cell immunity, murine cTRAMP prostate cancer cells were stably transfected with the pIRESneo vector expressing only APH (3‘) II as enzyme conferring the neomycin resistance or with the gp41-expressing pIRESneo vector.